Login / Signup
Jami Mandelin
ORCID
Publication Activity (10 Years)
Years Active: 2022-2022
Publications (10 Years): 1
Top Topics
Deep Learning
Skeletal Muscle
Cancer Therapy
Dendritic Cells
Top Venues
Molecular cancer therapeutics
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
Maija Hollmén
,
Mikael Maksimow
,
Jenna H Rannikko
,
Matti K Karvonen
,
Marita Vainio
,
Sirpa Jalkanen
,
Markku Jalkanen
,
Jami Mandelin
Nonclinical Characterization of Bexmarilimab, a Clever-1-Targeting Antibody for Supporting Immune Defense Against Cancers.
Molecular cancer therapeutics
21 (7) (2022)